NCT00024570 2014-11-14Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant GliomaINSYS Therapeutics IncPhase 1/2 Completed60 enrolled
NCT00378235 2014-11-13Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant GliomaINSYS Therapeutics IncPhase 1/2 Withdrawn
NCT00006268 2013-06-24Immunotoxin Therapy in Treating Patients With Malignant GliomaNational Cancer Institute (NCI)Phase 1/2 Completed
NCT00041587 2011-06-06Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant GliomaINSYS Therapeutics IncPhase 1/2 Completed80 enrolled